Close Menu

NEW YORK (GenomeWeb) – Great Basin on Monday said it plans to raise $3.5 million in net proceeds in a public offering of securities.

In a document filed with the US Securities and Exchange Commission, the firm said that it plans to offer 4 million units comprised of either Class A or Class B units, together with 4 million shares of common stock included in the Class A units, 20,000 shares of common stock underlying Series J warrants, and 4 million shares of common stock underlying prefunded Series K warrants.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.